Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2025.02.004 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Lachlan McDowell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Department of Radiation Oncology, Peter MacCallum Can…. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Sexual Health, Chemoradiotherapy, Papillomavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Royal Australian and New Zealand College of Radiologists.
Abstract (Originalsprache)
PURPOSE: This communication reports on the complete results of a prospective study evaluating sexual health and appearance-related outcomes in human papillomavirus-associated oropharyngeal cancer (HPVOPC) survivors treated with (chemo)radiation therapy ((C)RT). METHODS AND MATERIALS: One hundred patients with HPVOPC scheduled to receive curative-intent (C)RT were enrolled into a longitudinal observational study between October 2020 and November 2021. Sexual health was measured using the 22-item European Organisation for Research and Treatment of Cancer (EORTC) Sexual Health Questionnaire and appearance-related issues were measured using FACE-Q Appearance and Appearance distress modules. Questionnaires were administered before (C)RT, in the last week of treatment (week 7), and 3, 12, and 24 months after (C)RT. Linear mixed models estimated mean differences at follow-up assessments compared with before (C)RT. RESULTS: Global tests of differences across time provided moderate-to-strong evidence against the null hypothesis of no differences for all 22-item EORTC Sexual Health Questionnaire scales/items, apart from sexual pain and insecurity with partner (both P > .10). Compared with before (C)RT, the remainder of item/scale scores indicated worse sexual health in the last week of treatment, convalescing to pretreatment levels by 3 months (importance of sexual activity, worry incontinence), 12 months (sexual satisfaction, libido, fatigue affecting sex life), or 24 months (treatment affecting sex life, confidence in erection) after treatment. On average, feeling less masculine scores did not return to pretreatment levels by the final assessment. Appearance distress, but not facial appearance, was worse in the last week of treatment but improved by 3 months after treatment. CONCLUSIONS: Most sexual health outcomes impacted by (C)RT return to pretreatment levels by 3, 12, or 24 months. Temporary appearance distress was reported at the end of treatment. This communication provides multidimensional sexual health data to strengthen counseling of patients with HPVOPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Depart…
- Department of Cancer Experiences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Nursing, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Victor…
- Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Cancer Experiences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Förderung
- Royal Australian and New Zealand College of Radiologists
Zitieren
APA
McDowell, L., Gough, K., Fua, T., Coleman, A., Drosdowsky, A., Rischin, D., & Corry, J. (2025). Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.02.004
Vancouver
McDowell L, Gough K, Fua T, Coleman A, Drosdowsky A, Rischin D, et al. Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.02.004
BibTeX
@article{McDowell2025,
author = {McDowell, Lachlan and Gough, Karla and Fua, Tsien and Coleman, Andrew and Drosdowsky, Allison and Rischin, Danny and Corry, June},
title = {Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2025.02.004}
}
EUVIMED